NASDAQ-listed medical company, Semler Scientific (SMLR), has followed in the footsteps of MicroStrategy by adopting Bitcoin as its "primary treasury reserve asset." The firm initiated its strategy with a $40 million purchase of 581 BTC. The announcement led to a 38% surge in SMLR's stock price to a high of $33.25.

Chairman Eric Semler highlighted Bitcoin's status as a major asset class with a market value exceeding $1 trillion. He expressed confidence in Bitcoin's potential to serve as a hedge against inflation and a safe haven during global instability. Semler also compared Bitcoin to "digital gold", noting its architectural resilience and ease of movement.

The company will continue to evaluate how it uses its excess cash, with Bitcoin being its principal treasury holding, depending on market conditions and the company's anticipated cash needs. This move mirrors the strategy of MicroStrategy, which has accumulated over 214,000 BTC since August 2020, leading to a 1000% surge in its stock price.